Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26824-1-AP - Provider product page 
- Provider
- Proteintech Group
- Product name
- CPA4 antibody
- Antibody type
- Polyclonal
- Description
- CPA4 antibody (Cat. #26824-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references		CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells.
				
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4.
				
Carboxypeptidase A4 negatively regulates HGS-ETR1/2-induced pyroptosis by forming a positive feedback loop with the AKT signalling pathway.
				
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.
				
		
	
			Wang K, Ding Y, Liu Y, Ma M, Wang J, Kou Z, Liu S, Jiang B, Hou S
Journal of cellular and molecular medicine 2024 Apr;28(7):e18165
		Journal of cellular and molecular medicine 2024 Apr;28(7):e18165
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4.
			Liu X, Liang H, Fang H, Xiao J, Yang C, Zhou Z, Feng J, Chen C
Acta biochimica et biophysica Sinica 2023 May 9;55(9):1487-1495
		Acta biochimica et biophysica Sinica 2023 May 9;55(9):1487-1495
Carboxypeptidase A4 negatively regulates HGS-ETR1/2-induced pyroptosis by forming a positive feedback loop with the AKT signalling pathway.
			Wang L, Deng R, Chen S, Tian R, Guo M, Chen Z, Zhang Y, Li H, Liu Q, Tang S, Zhu H
Cell death & disease 2023 Dec 4;14(12):793
		Cell death & disease 2023 Dec 4;14(12):793
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.
			Kugeratski FG, Atkinson SJ, Neilson LJ, Lilla S, Knight JRP, Serneels J, Juin A, Ismail S, Bryant DM, Markert EK, Machesky LM, Mazzone M, Sansom OJ, Zanivan S
Science signaling 2019 Feb 5;12(567)
		Science signaling 2019 Feb 5;12(567)
				No comments: Submit comment	
	
			
			No validations: Submit validation data